A Short Patient-Reported Outcome Measure for Oral Anticancer Agents: Multicenter Observational Study
These results show that most RapidPROs reported at least one moderate or severe symptom and 28% (485/1705) reported medication nonadherence. As well, RapidPRO was able to capture most patients' MBSs. By implementing RapidPRO, practices can identify patients who experience symptoms, as well as those who report medication nonadherence.
Authors
- Vincent D. Marshall (ORCID: https://orcid.org/0000-0002-2594-7407)
- Jennifer J. Griggs (ORCID: https://orcid.org/0000-0002-1598-4562)
- Taylor M. Weis (ORCID: https://orcid.org/0000-0002-8337-0511)
- Karen B. Farris (ORCID: https://orcid.org/0000-0002-5636-3009)
- Kelly Romo
- Michelle Azar
- Emily Mackler
Institutions
- University of Michigan (US)
- Michigan Cancer Research Consortium (US)
Publication Details
- Journal
- JMIR Formative Research
- Published
- 2026-02-18
- DOI
- https://doi.org/10.2196/85201
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00